All commercial chemicals and solvents are reagent grade and were used without further
treatment unless otherwise noted. All reactions were carried out under an atmosphere of dry …

Vaccines remain the best measure to reduce total influenza burden. However, presently
available influenza vaccines have some limitations that cause a reduced efficacy compared …

Influenza A virus is a negative RNA stranded virus of the family Orthomyxoviridae, and
represents a major public health threat, compounding existing disease conditions. Influenza …

Influenza A is an acute respiratory infectious disease caused by the influenza A virus, which
seriously threatens global human health and causes substantial economic losses every …

In the advent of an influenza virus pandemic it is likely that the administration of antiviral
drugs will be an important first line of defence against the virus. The drugs currently in use …

Influenza viruses have acquired resistance to approved neuraminidase-targeting drugs,
increasing the need for new drug targets for the development of novel anti-influenza drugs …

Influenza A and B viruses are highly contagious respiratory pathogens with a considerable
medical and socioeconomical burden and known pandemic potential. Current influenza …

Influenza is still one of the major plagues worldwide with the potential to cause pandemics.
The increasing frequency of viral resistance to the four US Food and Drug Administration …

The influenza virus represents a permanent global health threat because it circulates not
only within but also between numerous host populations, thereby frequently causing …

Introduction Screening for effective antiviral compounds from traditional Mongolian medicine
not only aids in the research of antiviral mechanisms of traditional medicines, but is also of …